Eureka Correspondence

International investing, NewSat and superannuation.

International investing

The articles on international investing have been extremely interesting, and I for one would welcome periodic updates on the advantages and disadvantages of investing in each of the major international markets, not only the US!
Incidentally, I note that Tata Motors is no longer on the list of International stocks - is it expected to recover from its current slump?

Bill

Editor’s response: Thanks for your letter. Tata Motors had fallen off the list of international shares due to a technical glitch, and it's back there now: http://www.eurekareport.com.au/share-recommendations/international.

NewSat

Would Mr Gottliebsen care to give an update?

Name withheld

Editor’s response: Thanks for your letter. Eureka Report discontinued coverage of NewSat in July last year. The article explaining the reasons for this decision is here.

Superannuation

Robert,
You are all missing something, super earnings includes capital appreciation not just income. Any well run SMSF has earned about 15% for each of the past 3 years. so the base for Bill's tax is about $500,000 not $1,000,000. To make it worse we will have to sell assets to pay Bill his tax and then in a bad year will he give us a credit? How many SMSFs are out there where a contributor has a balance of $500,000 or is getting close to it? Not the small number he is talking about. Talk about an own goal.

David

I do not understand Robert’s tacit support of taxing super income above $75000 whilst being strongly against taxing pensions, are not retirement income streams referred to as account-based pensions?

Gavin

InvestSMART FORUM: Come and meet the team

We're loading up the van and going on tour from April to June, with events on the NSW central & north coast, the QLD mid-north coast and in Perth, Adelaide, Melbourne, Sydney and Canberra. Come and meet the team and take home simple strategies that you can use to build an investment portfolio to weather any storm. Book your spot here.

Want access to our latest research and new buy ideas?

Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.

Sign up for free

Related Articles